In Insider Trading, Executive Director of Murphy Oil Buys and Vice Chairman of Goldman Sachs Sells
By
Jonathan Moreland
Feb 15, 2013 10:20 am
Plus, purchases at Genomic Health and Wet Seal, and sales at Roadrunner Transportation Systems, Google, and Estee Lauder.
In a victory for common sense, the trading behavior of company executives, directors, and large shareholders in the stocks of firms they're registered "insiders" at have been proven profitable to monitor by both academic studies and (more importantly) the experience of your fellow professional investors.
Below are lists of the top 10 mainly open-market insider purchases and sales filed at the Securities and Exchange Commission Thursday, February 14, 2013 as ranked by dollar value.
Please note, however, that these are factual lists, not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.
In insider purchases, Claiborne Deming, the former President and CEO and now Executive Director of Murphy Oil Corp. (NYSE:MUR), bought $4,827,425 of company stock. At Genomic Health (NASDAQ:GHDX), which develops and commercializes genomic-based laboratory services for the analysis of cancer, Director Felix Baker bought $1,480,987 of company stock. John Goodman, the CEO of women's clothing retailer Wet Seal (NASDAQ:WTSLA), bought $649,377 of company stock.
In insider sales, Google (NASDAQ:GOOG) CEO and Co-Founder Larry Page sold $16,341,570 of company stock. At Roadrunner Transportation Systems (NYSE:RRTS), which provides asset-light transportation and logistics services, the private equity firm Eos Capital, a Beneficiary Owner, sold $8,400,000. Michael Sherwood, the Vice Chairman of Goldman Sachs (NYSE:GS), sold $7,601,310 of company shares. William Lauder's 1992 GRAT Remainder Trust, a Beneficiary Owner and Trustee of skin care, cosmetic, fragrance, and hair company Estee Lauder (NYSE:EL), sold $6,274,500 of company shares.
At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.
Below are lists of the top 10 mainly open-market insider purchases and sales filed at the Securities and Exchange Commission Thursday, February 14, 2013 as ranked by dollar value.
Please note, however, that these are factual lists, not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.
In insider purchases, Claiborne Deming, the former President and CEO and now Executive Director of Murphy Oil Corp. (NYSE:MUR), bought $4,827,425 of company stock. At Genomic Health (NASDAQ:GHDX), which develops and commercializes genomic-based laboratory services for the analysis of cancer, Director Felix Baker bought $1,480,987 of company stock. John Goodman, the CEO of women's clothing retailer Wet Seal (NASDAQ:WTSLA), bought $649,377 of company stock.
In insider sales, Google (NASDAQ:GOOG) CEO and Co-Founder Larry Page sold $16,341,570 of company stock. At Roadrunner Transportation Systems (NYSE:RRTS), which provides asset-light transportation and logistics services, the private equity firm Eos Capital, a Beneficiary Owner, sold $8,400,000. Michael Sherwood, the Vice Chairman of Goldman Sachs (NYSE:GS), sold $7,601,310 of company shares. William Lauder's 1992 GRAT Remainder Trust, a Beneficiary Owner and Trustee of skin care, cosmetic, fragrance, and hair company Estee Lauder (NYSE:EL), sold $6,274,500 of company shares.
At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.
| #: | Filer Name | Insider Titles | Company Name | Ticker |
Trans Type |
Dollar Value |
|---|---|---|---|---|---|---|
|
1
|
DIR
|
B
|
$4,827,425
|
|||
|
2
|
BO
|
JB*
|
$2,691,000
|
|||
|
3
|
DIR,BO
|
B
|
$1,480,987
|
|||
|
4
|
CEO
|
B
|
$649,377
|
|||
|
5
|
BO
|
B
|
$615,000
|
|||
|
6
|
BO
|
B
|
$586,500
|
|||
|
7
|
DIR
|
B
|
$392,200
|
|||
|
8
|
CEO,CB,BO
|
B
|
$133,335
|
|||
|
9
|
DIR
|
B
|
$132,580
|
|||
|
10
|
CB,CEO,FO
|
JB*,B
|
$107,588
|
Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes
| #: | Filer Name | Insider Titles | Company Name | Ticker |
Trans Type |
Dollar Value |
|---|---|---|---|---|---|---|
|
1
|
CEO,DIR,BO
|
AS
|
$16,341,570
|
|||
|
2
|
BO
|
S
|
$12,353,007
|
|||
|
3
|
BO
|
S
|
$8,400,000
|
|||
|
4
|
VCB
|
S
|
$7,601,310
|
|||
|
5
|
TT,BO
|
AS
|
$6,274,500
|
|||
|
6
|
BO
|
JS*
|
$2,730,894
|
|||
|
7
|
BO
|
S
|
$2,573,564
|
|||
|
8
|
BO
|
S
|
$2,554,425
|
|||
|
9
|
VP
|
S
|
$2,441,242
|
|||
|
10
|
BO
|
S
|
$2,281,045
|
Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes
Editor's note: Jonathan Moreland is the founder of Insider Insights and author of "Profit From Legal Insider Trading." No positions in stocks mentioned.


Daily Recap
Everything you need to know for the next trading day.
Trading Radar (weekly)
Your road map to all the events that will effect financial markets in the week ahead.
Name
Email
*
Phone

* required field

business news
PRINT























